DES Raises ADHD Risk in Grandchildren
The grandchildren of women who took the endocrine disrupter diethylstilbestrol (DES) during pregnancy face increased risk for attention-deficit/hyperactivity disorder (ADHD), according to results published online today in JAMA Pediatrics. From 1938 through 1971, 5 to 10 million women in the United States were prescribed DES during pregnancy.
Other Articles in this Edition
Unnecessary and accidental use of ADHD drugs on the rise, study finds
DES Raises ADHD Risk in Grandchildren
Meditation and Mindfulness for ADHD: A Brief Review
6 Reasons for Common Psych Diagnostic Mistakes
Will Adderall Be the New Opioid Crisis?
Increased Risk for Type 2 Diabetes in Adolescents, Young Adults With ADHD
HealthWatch: ADHD Medication Warning, Doctors Recording Conversations
ADHD a biological condition, not just behavioral, new research shows
NRA’s incoming president ties Ritalin to school shootings, but here’s what the science says